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The experiment was carried out in order to observe the effects of several coronary vasodilators by the coronary sinus catheterization technic. Four coronary vasodilators, including N-[3'-phenyl-propyl-(2')]-1, 1-diphenyl-propyl-(3)-amin (Segontin), 2, 6-bis (diaethanolamino)-4, 8-dipiperidino-pyrimido-(5, 4-d) pyrimidin (Persantin), 7-chlorethyltheophylline (ETE) and Papaverine hydrochloride were applied to 19 subjects with coronary sclerotic heart disease.
Segontin, Persantin and ETE increased the coronary blood flow accompanied in part by the rise of mean diastolic pressure. However, the results indicated that some other direct or indirect effects of these drugs on the coronary vasculature may be present. Papaverine hydrochloride reduced coronary blood flow in parallel with the decrease of mean diastolic pressure.
Among 4 drugs, only Persantin decreased the coronary vascular resistance, although the tested drugs except ETE decreased or had the tendency to decrease the coronary-systemic resistance ratio i.e. the relative coronary resistance.
On the other hand, the myocardial oxygen unbalance in these patients was improved by Persantin, unchanged after Segontin and Papaverine hydrochloride, and increased after ETE. E 
MATERIALS AND METHODS
Nineteen subjects with coronary sclerotic heart disease were chosen for analysis, as shown in Table I .
Thirteen cases with coronary insufficiency consisted of those with ischaemic ST-T changes in the resting electrocardiograms or with positive standard Master's two step test. Five cases with angina pectoris and one with old myocardial infarction were also included. Coronary sinus catheterization was carried out on each subject at about more than 8 hours postprandial state. Coronary blood flow was measured by nitrous oxide desaturation technic.
Blood pressure was recorded directly in the brachial artery with strain gauge transducer MP-3 (Nihon Kohden) in 12 cases of 19 subjects, and remainders were measured by the auscultation.
In 19 cases were administered the various vasodilators. The dosage of the applied coronary vasodilators, the route of administration and the time interval between the use of medication and the second measurement were as follows: 
RESULTS
The individual data of coronary hemodynamics and blood gas analysis before and after administration of coronary vasodilators were illustrated in Table II. 1) Effects on coronary blood flow (CBF) As shown in Fig.1 and Table II , the coronary blood flow (ml./100Gm./ min.) was increased by the administration of ETE (18%, p<0.02), Segontin (11%) and Persantin (16%) respectively. On the other hand, CBF decreased average 14 per cent following Papaverine . nearly along the regression line, although the lesser increase of CBF than that of MOC was observed after ETE. Papaverine reduced CBF and MOC similarly (Fig.4) .
As shown in Fig.5 , CBF is reversely correlated with coronary vascular resistance (r=-0.54, p<0.01).
Coronary blood flow changed after administration of Segontin , ETE and Papaverine without any appreciable change of coronary vascular resistance , while Persantin increased CBF with tendency to decrease coronary vascular resistance. II) Effects on myocardial oxygen consumption (MOC) Myocardial oxygen consumption was increased by the administration of ETE (32%, p<0.05), Segontin (9%) and Persantin (12%) respectively. Papaverine reduced MOC (-10%) (Fig.6 and Table II) .
MOC was markedly related with myocardial oxygen supply as reported8) previously (r=0.93, p<0.001). MOC increased by Segontin and Persantin 
DISCUSSION
It is known that coronary vasodilators increase coronary blood flow by coronary arterial dilatation in normal subjects or animal experiments.
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cording to Gorlin et al.,2) on the other hand, coronary vascular resistance in coronary sclerotic hearts is already fallen to minimum value, indicating nearly maximal arterial dilatation in that sclerotic condition, and thus the dilatatory capacity is so limited that the coronary blood flow is difficult to increase furthermore by dilators. When this argument is correct, the augmentation of the coronary blood flow under these conditions is practically depend on a rise of the perfusion pressure. The perfusion pressure was reported as the regulator of the coronary blood flow by several investigators.10)-12) Kojima8) also reported previously that mean diastolic pressure correlated most linearly with the coronary blood flow in 14 coronary sclerotic patients, since the stage of coronary inflow almost coincided with diastolic phase.13) For the elevation of the coronary blood flow in coronary sclerosis, it is necessary to maintain the aortic mean diastolic pressure at a certain height, and the drugs having such an action may be able to raise coronary blood flow. As shown in Fig.2 , Segontin, Persantin and ETE increased coronary blood flow accompanied by the rise of mean diastolic pressure. However, the grade of increment in coronary blood flow was slightly greater than that of mean diastolic pressure as compared with the regression line. This deviated increase in coronary blood flow from the regression line seems to indicate that some other factors than mean diastolic pressure may be concerned with the increase of coronary blood flow after the administration of these drugs.
Segontin was tended to decrease not the coronary vascular resistance but the coronary-systemic resistance ratio (CR/SR) (-17%, Fig.8 and Table  II) , and increased coronary blood flow following relative coronary vasodilatation. Segontin is also known as a drug having a reversible MAO inhibitory14) or sympathicolytic action,15) and such actions of this drug might change the Fig.8 .
Changes of coronary-systemic resistance ratio after coronary vasodila- 
